Lv51
1073 积分 2023-10-27 加入
P53 Binding Protein 1 (53bp1) Is an Early Participant in the Cellular Response to DNA Double-Strand Breaks
3天前
已完结
Radiotheranostic landscape: A review of clinical and preclinical development
3天前
已完结
Integrated radio-theranostics using a [ 89 Zr]Zr-/[ 177 Lu]Lu-labeled B7-H3 antibody-drug conjugate for prostate cancer
26天前
已完结
Preclinical Evaluation of68Ga/177Lu-Labeled FAP-Targeted Peptide for Tumor Radiopharmaceutical Imaging and Therapy
26天前
已完结
Primary Renal Neuroendocrine Tumor Demonstrated on 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT
26天前
已完结
68Ga-FAPI-04 PET/CT in Renal NUT Carcinoma
26天前
已完结
Preclinical Evaluation of 5T4-Targeted [ 89 Zr]Zr-DFO-HB5 Immuno-PET Imaging and Comparison of 161 Tb vs 177 Lu Radionuclide Therapy for Colorectal Cancer
26天前
已完结
Recent advances and impending challenges for the radiopharmaceutical sciences in oncology
27天前
已完结
Radiopharmaceutical therapy in cancer: clinical advances and challenges
27天前
已完结
Radiopharmaceuticals
27天前
已完结
皖公网安备34019202002308
